Obesity strategy should not be built around a single drug Tirzepatide (Mounjaro) has had a remarkable journey to prominence since its UK marketing authorisation in 2023.1 Approved for glycaemic ...

As a doctor with lived experience of an eating disorder, I know that there is a huge amount we can do to educate ourselves better about eating disorders to improve patient care and experiences, writes ...